Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vogl

Showing results (291-300 of 342) with videos related to

Pageof 35
Sort By:
Ejhaem|July 18, 2022
Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myelomaPaul G Richardson, Sundar Jagannath, Ajai Chari, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Blood|September 25, 2010
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trialEdward A Stadtmauer, Dan T Vogl, Eline Luning Prak, et al.
Osteoarthritis and Cartilage|July 23, 2021
A single dose of anti-IL-1β antibodies prevents Western diet-induced immune activation during early stage collagenase-induced osteoarthritis, but does not ameliorate end-stage pathologyN N L Kruisbergen, Y van Gemert, B Walgreen, et al.
Osteoarthritis and Cartilage|August 13, 2016
Synovial macrophages promote TGF-β signaling and protect against influx of S100A8/S100A9-producing cells after intra-articular injections of oxidized low-density lipoproteinsW de Munter, E J W Geven, A B Blom, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritisR F Schelbergen, E J Geven, M H J van den Bosch, et al.
Blood Cancer Journal|February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Osteoarthritis and Cartilage|September 23, 2016
Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritisS C M van Dalen, A B Blom, A W Slöetjes, et al.
Pageof 35

Showing results (291-300 of 342) with videos related to

Sort By:
Pageof 35
Ejhaem|July 18, 2022
Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myelomaPaul G Richardson, Sundar Jagannath, Ajai Chari, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Blood|September 25, 2010
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trialEdward A Stadtmauer, Dan T Vogl, Eline Luning Prak, et al.
Osteoarthritis and Cartilage|July 23, 2021
A single dose of anti-IL-1β antibodies prevents Western diet-induced immune activation during early stage collagenase-induced osteoarthritis, but does not ameliorate end-stage pathologyN N L Kruisbergen, Y van Gemert, B Walgreen, et al.
Osteoarthritis and Cartilage|August 13, 2016
Synovial macrophages promote TGF-β signaling and protect against influx of S100A8/S100A9-producing cells after intra-articular injections of oxidized low-density lipoproteinsW de Munter, E J W Geven, A B Blom, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritisR F Schelbergen, E J Geven, M H J van den Bosch, et al.
Blood Cancer Journal|February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Osteoarthritis and Cartilage|September 23, 2016
Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritisS C M van Dalen, A B Blom, A W Slöetjes, et al.
Pageof 35